Insiders NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-10 pm EDT			5-day change	1st Jan Change
4.54 ^USD	+0.22%		+1.56%	+22.82%

Jun. 26	NeuroBo Pharmaceuticals, Inc. Doses First Patient in the MAD Part 2 of its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity	CI
Jun. 26	NeuroBo Pharmaceuticals Raises $20 Million from Share Placement	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NeuroBo Pharmaceuticals Names Marshall Woodworth Finance Chief	Mar. 04	MT
NeuroBo Pharmaceuticals, Inc. Appoints James P. Tursi to its Board of Directors and as Member of Nominating and Corporate Governance Committee	Nov. 06	CI
NeuroBo Pharmaceuticals, Inc. Appoints Marshall H. Woodworth as Principal Financial Officer and Principal Accounting Officer	23-10-30	CI
NeuroBo Pharmaceuticals, Inc. Announces Resignation of Na Yeon Kim from the Board of Directors	23-09-19	CI
NeuroBo Pharmaceuticals Names Hyung Heon Kim CEO, President	23-08-14	MT
Neurobo Pharmaceuticals, Inc. Announces the Appointment of Current Board Member, Hyung Heon ("H.H.") Kim as the Company's President, Principal Executive Officer, and Principal Accounting Officer	23-08-14	CI
NeuroBo Pharmaceuticals, Inc. Announces Executive Changes	23-08-14	CI
Neurobo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to Its Board of Directors	23-05-12	CI
NeuroBo Pharmaceuticals Names Joseph Hooker Interim Chief Executive	23-01-18	MT
NeuroBo Pharmaceuticals, Inc. Appoints Joseph Hooker as President	23-01-18	CI
NeuroBo Pharmaceuticals, Inc. Announces CEO Changes	23-01-18	CI
Neurobo Pharmaceuticals, Inc. Appoints Matthew Bardin as Senior Vice President Operations	22-05-06	CI
Neurobo Pharmaceuticals, Inc. Appoints Danamarie Belpulsi to Scientific Advisory Board	22-03-15	CI
NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors	22-01-28	CI
Neurobo Pharmaceuticals, Inc. Announces Management Changes	22-01-14	CI
NeuroBo Pharmaceuticals announces executive changes	21-11-04	CI
NeuroBo Pharmaceuticals, Inc. Announces Executive Changes	21-11-04	CI
Neurobo Pharmaceuticals, Inc. Elects Hyung Heon Kim and Andrew I. Koven to Board of Directors	21-07-12	CI
NeuroBo Pharmaceuticals, Inc. Announces Retirement of Jeong Gyun Oh from the Board	21-05-14	CI
NeuroBo Pharmaceuticals, Inc. Announces Board Changes	21-03-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders NeuroBo Pharmaceuticals, Inc.

Equities

NRBO

US64132R4048

Insiders

Filters